首页> 中文期刊> 《中国生化药物杂志》 >川芎嗪注射液联合尼莫地平治疗原发性开角型青光眼的疗效观察

川芎嗪注射液联合尼莫地平治疗原发性开角型青光眼的疗效观察

         

摘要

目的 观察川芎嗪注射液联合尼莫地平治疗原发性开角型青光眼的疗效.方法 我院眼科诊治的112例原发性开角型青光眼患者随机分为2组,各56例.2组均进行尼莫地平常规治疗,观察组另加用川芎嗪注射液,分析其疗效.结果 治疗后,观察组视网膜光敏感度、视野缺损、血流量、血流速度、红细胞移动率、视网膜中央动脉PSV、EDV和RI均优于对照组(均P<0.05).2组不良反应情况比较差异无统计学意义.结论 川芎嗪注射液可改善原发性开角型青光眼视网膜中央动脉和视盘筛板血流状况,改善视网膜光敏感度和视野缺损.%Objective To observe the effect of Chuanxiongqin injection combined with nimodipine on primary open angle glaucoma.Methods 112 patients with primary open angle glaucoma in ophthalmology department were grouped two groups,each with 56 cases.Two groups were treated with nimodipine and observation group was treated another with Chuanxiongqin injection to observe effect.Results After treatment,retinal light sensitivity,visual field defect,blood flow,blood flow velocity,erythrocyte migration rate,PSV,EDV and RI in central retinal artery of observation group were better than control group(P<0.05).There was no significant difference in adverse reactions between groups.Conclusion Chuanxiongqin injection can improve blood flow status of central retinal artery and optic papillary laminar, retinal light sensitivity and visual field defect for patients with primary open angle glaucoma.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号